Emily C Hancin, William Y Raynor, Austin J Borja, Thomas J Werner, Mona-Elisabeth Revheim, Abass Alavi
Journal: PET clinics 2021;16(2):273-284
PMID: 33589388
F-fluorodeoxyglucose (F-FDG) and F-sodium fluoride (F-NaF) are front-runners in PET. However, these tracers have limitations in the imaging of diseases in the heart. A multitude of other radiotracers have been identified as potentially useful PET agents in the identification of cardiovascular disease. This critical review examines recent studies with the use of non-F-FDG/F-NaF radiotracers in the identification and surveillance of cardiovascular diseases. We highlight the need for further investigation into alternative PET radiotracers to demonstrate their clinical value in the management of these pathologies.
Copyright © 2020 Elsevier Inc. All rights reserved.
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.